146 related articles for article (PubMed ID: 37865224)
1. Serum vitamin D is associated with ultrasound-defined hepatic fibrosis.
Jiang R; Zhou Y; Han L; Hong Z
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102228. PubMed ID: 37865224
[TBL] [Abstract][Full Text] [Related]
2. Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017-2018.
Ji Y; Wei CB; Gu W; Hou LL
Ann Med; 2023 Dec; 55(1):2209335. PubMed ID: 37155562
[TBL] [Abstract][Full Text] [Related]
3. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease.
Zhao Y; Li H
Scand J Gastroenterol; 2022 Jul; 57(7):872-877. PubMed ID: 35189786
[TBL] [Abstract][Full Text] [Related]
4. Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis.
Ciardullo S; Muraca E; Cannistraci R; Perra S; Lattuada G; Perseghin G
Diabetes Metab Res Rev; 2023 Jul; 39(5):e3628. PubMed ID: 36815587
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
Alkhouri N; Almomani A; Le P; Payne JY; Asaad I; Sakkal C; Vos M; Noureddin M; Kumar P
BMC Gastroenterol; 2022 Jul; 22(1):366. PubMed ID: 35907827
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound.
Ding Y; Jiang L; Wang Q; Zhao W; Zhou X; Lu J; Tian T; Yu C; Xu X; Guo W; Zhang Q; Song C
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101951. PubMed ID: 35605893
[TBL] [Abstract][Full Text] [Related]
7. The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018.
Liu J; Tan L; Liu Z; Shi R
Ann Med; 2022 Dec; 54(1):2259-2268. PubMed ID: 35975984
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
Zhang X; Heredia NI; Balakrishnan M; Thrift AP
PLoS One; 2021; 16(6):e0252164. PubMed ID: 34081733
[TBL] [Abstract][Full Text] [Related]
9. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
Siddiqui MS; Vuppalanchi R; Van Natta ML; Hallinan E; Kowdley KV; Abdelmalek M; Neuschwander-Tetri BA; Loomba R; Dasarathy S; Brandman D; Doo E; Tonascia JA; Kleiner DE; Chalasani N; Sanyal AJ;
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):156-163.e2. PubMed ID: 29705261
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China.
Yu XY; Song XX; Tong YL; Wu LY; Song ZY
Medicine (Baltimore); 2020 Nov; 99(48):e23360. PubMed ID: 33235107
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
12. NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population.
Ciardullo S; Muraca E; Zerbini F; Manzoni G; Perseghin G
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2856-e2865. PubMed ID: 33878156
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.
Long MT; Zhang X; Xu H; Liu CT; Corey KE; Chung RT; Loomba R; Benjamin EJ
Hepatology; 2021 Feb; 73(2):548-559. PubMed ID: 33125745
[TBL] [Abstract][Full Text] [Related]
14. The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults.
Yang N; Lu Y; Cao L; Lu M
J Clin Lab Anal; 2022 Feb; 36(2):e24225. PubMed ID: 34997649
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the mediating role of BMI in associations of different folate forms with hepatic steatosis and liver fibrosis in adolescents in the USA: results from the NHANES 2017-2018.
Wen J; Fei Y; Yuan L; Li K; Xu Q; Cao X; Su J; Zhu Y; Zhang Z
Front Endocrinol (Lausanne); 2023; 14():1273580. PubMed ID: 38116318
[TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population.
Ciardullo S; Ballabeni C; Trevisan R; Perseghin G
Dig Liver Dis; 2021 Jul; 53(7):866-872. PubMed ID: 33685807
[TBL] [Abstract][Full Text] [Related]
18. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
19. Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.
Liu CF; Chien LW
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111111
[TBL] [Abstract][Full Text] [Related]
20. Association between frailty and hepatic fibrosis in NAFLD among middle-aged and older adults: results from NHANES 2017-2020.
Atabieke F; Li XJ; Aierken A; Li J; Zhang Y; Aizezi Y; Gao HL; Zhang ZQ
Front Public Health; 2024; 12():1330221. PubMed ID: 38389936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
